Cross Country Healthcare, Inc. (CCRN) Lowered to C+ at TheStreet
Other research analysts also recently issued reports about the company. Zacks Investment Research upgraded Cross Country Healthcare from a sell rating to a hold rating in a research report on Tuesday, July 11th. Benchmark Co. reiterated a buy rating and issued a $17.00 price target (down from $18.00) on shares of Cross Country Healthcare in a report on Wednesday, August 9th. BidaskClub downgraded Cross Country Healthcare from a sell rating to a strong sell rating in a report on Monday, July 24th. Cantor Fitzgerald reiterated a buy rating and issued a $18.00 price target on shares of Cross Country Healthcare in a report on Wednesday, November 1st. Finally, BMO Capital Markets dropped their price objective on Cross Country Healthcare from $15.00 to $14.00 and set an outperform rating for the company in a report on Monday. Two analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the stock. Cross Country Healthcare currently has an average rating of Hold and a consensus price target of $15.31.
Shares of Cross Country Healthcare (CCRN) traded down $0.35 during trading hours on Friday, hitting $11.76. The stock had a trading volume of 260,272 shares, compared to its average volume of 165,698. The stock has a market cap of $420.78, a price-to-earnings ratio of 18.92, a price-to-earnings-growth ratio of 1.05 and a beta of 0.77. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.14 and a quick ratio of 2.24. Cross Country Healthcare has a fifty-two week low of $11.07 and a fifty-two week high of $16.38.
Cross Country Healthcare (NASDAQ:CCRN) last announced its quarterly earnings results on Wednesday, November 1st. The business services provider reported $0.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.05. The business had revenue of $228.50 million for the quarter, compared to analyst estimates of $228.97 million. Cross Country Healthcare had a return on equity of 11.69% and a net margin of 0.19%. The company’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.24 EPS. sell-side analysts expect that Cross Country Healthcare will post 0.66 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/cross-country-healthcare-inc-ccrn-lowered-to-c-at-thestreet/1685714.html.
In other Cross Country Healthcare news, insider William J. Grubbs sold 49,113 shares of the company’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $12.16, for a total value of $597,214.08. Following the completion of the transaction, the insider now directly owns 395,188 shares of the company’s stock, valued at approximately $4,805,486.08. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Thomas C. Dircks acquired 10,000 shares of the firm’s stock in a transaction on Monday, November 6th. The stock was purchased at an average cost of $11.77 per share, with a total value of $117,700.00. Following the completion of the transaction, the director now owns 104,571 shares in the company, valued at $1,230,800.67. The disclosure for this purchase can be found here. 3.90% of the stock is currently owned by corporate insiders.
A number of large investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in Cross Country Healthcare by 4.7% in the 2nd quarter. Vanguard Group Inc. now owns 1,919,676 shares of the business services provider’s stock valued at $24,783,000 after buying an additional 86,718 shares during the last quarter. Benefit Street Partners LLC boosted its position in Cross Country Healthcare by 30.9% in the 2nd quarter. Benefit Street Partners LLC now owns 1,544,440 shares of the business services provider’s stock valued at $19,939,000 after buying an additional 364,229 shares during the last quarter. Simcoe Capital Management LLC boosted its position in Cross Country Healthcare by 120.9% in the 2nd quarter. Simcoe Capital Management LLC now owns 1,227,590 shares of the business services provider’s stock valued at $15,848,000 after buying an additional 671,885 shares during the last quarter. State Street Corp boosted its position in Cross Country Healthcare by 9.8% in the 2nd quarter. State Street Corp now owns 876,998 shares of the business services provider’s stock valued at $11,323,000 after buying an additional 78,451 shares during the last quarter. Finally, Royce & Associates LP boosted its position in Cross Country Healthcare by 36.7% in the 2nd quarter. Royce & Associates LP now owns 792,464 shares of the business services provider’s stock valued at $10,231,000 after buying an additional 212,778 shares during the last quarter. 95.83% of the stock is owned by institutional investors.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.
Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.